| Literature DB >> 31693991 |
Nadeem R Abu-Rustum1, Catheryn M Yashar2, Sarah Bean3, Kristin Bradley4, Susana M Campos5, Hye Sook Chon6, Christina Chu7, David Cohn8, Marta Ann Crispens9, Shari Damast10, Oliver Dorigo11, Patricia J Eifel12, Christine M Fisher13, Peter Frederick14, David K Gaffney15, Ernest Han16, Warner K Huh17, John R Lurain18, Andrea Mariani19, David Mutch20, Christa Nagel21, Larissa Nekhlyudov5, Amanda Nickles Fader22, Steven W Remmenga23, R Kevin Reynolds24, Rachel Sisodia25, Todd Tillmanns26, Stefanie Ueda27, Emily Wyse28, Nicole R McMillian29, Jillian Scavone29.
Abstract
Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.Entities:
Mesh：
Year: 2019 PMID： 31693991 DOI： 10.6004/jnccn.2019.0053
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908